Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences

OBJECTIVES: To assess first clinical experiences with brivaracetam (BRV) in the treatment of epilepsies. METHODS: Data on patients treated with BRV from February to December 2016 and with at least one clinical follow-up were collected from electronic patient records. Data on safety and efficacy were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahnert, Felix, Krause, Kristina, Immisch, Ilka, Habermehl, Lena, Gorny, Iris, Chmielewska, Izabella, Möller, Leona, Weyand, Anna M., Mross, Peter M., Wagner, Jan, Menzler, Katja, Knake, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808159/
https://www.ncbi.nlm.nih.gov/pubmed/29467714
http://dx.doi.org/10.3389/fneur.2018.00038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808159/
https://www.ncbi.nlm.nih.gov/pubmed/29467714
http://dx.doi.org/10.3389/fneur.2018.00038

Ejemplares similares